Alprazolam Extended-release Tablets 3 mg

DRUG2 trials

Sponsors

Mylan Pharmaceuticals Inc

Conditions

Healthy

Phase 1

Fed Study of Alprazolam Extended-release Tablets 3 mg to Xanax XR® Tablets 3 mg

CompletedNCT00650299

Mylan Pharmaceuticals IncHealthy

Start: 2004-08-31End: 2004-08-31Updated: 2024-04-24

Fasting Study of Alprazolam Extended-Release Tablets 3 mg to Xanax XR® Tablets 3 mg

CompletedNCT00647634

Mylan Pharmaceuticals IncHealthy

Start: 2004-08-31End: 2004-08-31Updated: 2024-04-24